Homozygous Familial Hypercholesterolemia Treatment Market Report

China Homozygous Familial Hypercholesterolemia Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 29, 2023
  • PAGES：204
  • REPORT CODE：GMM1818362
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Homozygous Familial Hypercholesterolemia Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Gemphire Therapeutics Inc

    • The Medicines Company

    • Regeneron Pharmaceuticals Inc

    • Daewoong Co Ltd

    • LipimetiX Development Inc

    • CymaBay Therapeutics Inc

    By Type:

    • AEM-2814

    • Alirocumab

    • Evinacumab

    • AEM-2802

    • Others

    By Application:

    • Hospital

    • Others

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Homozygous Familial Hypercholesterolemia Treatment Market Overview 2018-2029

    • 1.1 China Homozygous Familial Hypercholesterolemia Treatment Industry Development Overview

    • 1.2 China Homozygous Familial Hypercholesterolemia Treatment Industry Development History

    • 1.3 China Homozygous Familial Hypercholesterolemia Treatment Industry Market Size (2018-2029)

    • 1.4 China Homozygous Familial Hypercholesterolemia Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of AEM-2814 (2018-2029)

      • 1.4.2 China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of Alirocumab (2018-2029)

      • 1.4.3 China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of Evinacumab (2018-2029)

      • 1.4.4 China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of AEM-2802 (2018-2029)

      • 1.4.5 China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Homozygous Familial Hypercholesterolemia Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Homozygous Familial Hypercholesterolemia Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Homozygous Familial Hypercholesterolemia Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Homozygous Familial Hypercholesterolemia Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Homozygous Familial Hypercholesterolemia Treatment Market Analysis by Region

      • 1.6.1 North China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Homozygous Familial Hypercholesterolemia Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Homozygous Familial Hypercholesterolemia Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Homozygous Familial Hypercholesterolemia Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Homozygous Familial Hypercholesterolemia Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Homozygous Familial Hypercholesterolemia Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Homozygous Familial Hypercholesterolemia Treatment Industry Development

    Chapter 3 Homozygous Familial Hypercholesterolemia TreatmentIndustry Chain Analysis

    • 3.1 Homozygous Familial Hypercholesterolemia Treatment Industry Chain

    • 3.2 Homozygous Familial Hypercholesterolemia Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Homozygous Familial Hypercholesterolemia Treatment Market

    • 3.3 Homozygous Familial Hypercholesterolemia Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Homozygous Familial Hypercholesterolemia Treatment Market

    Chapter 4 China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 4.1 China Homozygous Familial Hypercholesterolemia Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Homozygous Familial Hypercholesterolemia Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of AEM-2814

      • 4.5.2 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of Alirocumab

      • 4.5.3 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of Evinacumab

      • 4.5.4 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of AEM-2802

      • 4.5.5 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of Others

    Chapter 5 China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Homozygous Familial Hypercholesterolemia Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate of Hospital

      • 5.5.2 China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate of Others

      • 5.5.3 China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate of Clinic

    Chapter 6 China Homozygous Familial Hypercholesterolemia Treatment Market, by Region

    • 6.1 China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Production Value, by Region

    • 6.2 China Homozygous Familial Hypercholesterolemia Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 7.1 North China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 7.2 North China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 8 Central China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 8.1 Central China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 8.2 Central China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 9 South China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 9.1 South China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 9.2 South China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 10 East China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 10.1 East China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 10.2 East China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 11 Northeast China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 11.1 Northeast China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 11.2 Northeast China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 12 Southwest China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 12.1 Southwest China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 12.2 Southwest China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 13 Northwest China Homozygous Familial Hypercholesterolemia Treatment Market Analysis

    • 13.1 Northwest China Homozygous Familial Hypercholesterolemia Treatment Market, by Type

    • 13.2 Northwest China Homozygous Familial Hypercholesterolemia Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Gemphire Therapeutics Inc

        • 14.1.1 Gemphire Therapeutics Inc Company Profile

        • 14.1.2 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 The Medicines Company

        • 14.2.1 The Medicines Company Company Profile

        • 14.2.2 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Regeneron Pharmaceuticals Inc

        • 14.3.1 Regeneron Pharmaceuticals Inc Company Profile

        • 14.3.2 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Daewoong Co Ltd

        • 14.4.1 Daewoong Co Ltd Company Profile

        • 14.4.2 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 LipimetiX Development Inc

        • 14.5.1 LipimetiX Development Inc Company Profile

        • 14.5.2 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 CymaBay Therapeutics Inc

        • 14.6.1 CymaBay Therapeutics Inc Company Profile

        • 14.6.2 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Homozygous Familial Hypercholesterolemia Treatment Industry Research Conclusions

    • 15.2 Homozygous Familial Hypercholesterolemia Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Industry Market Size (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of AEM-2814 (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of Alirocumab (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of Evinacumab (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of AEM-2802 (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Homozygous Familial Hypercholesterolemia Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Share by Type in 2018

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Share by Type in 2023

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of AEM-2814 (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of Alirocumab (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of Evinacumab (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of AEM-2802 (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Share by Application in 2018

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Share by Application in 2023

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate of Others (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Region (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Production Value by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Production Value Share by Region (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Production Value Share by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Sales Value by Region (2018-2023)

    • Table China Homozygous Familial Hypercholesterolemia Treatment Sales Value Share by Region (2018-2023)

    • Figure China Homozygous Familial Hypercholesterolemia Treatment Sales Value Share by Region (2018-2023)

    • Table North China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table North China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table North China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table North China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table Central China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table Central China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table South China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table South China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table South China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table East China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table East China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table East China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Homozygous Familial Hypercholesterolemia Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Homozygous Familial Hypercholesterolemia Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Homozygous Familial Hypercholesterolemia Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Homozygous Familial Hypercholesterolemia Treatment Sales Volume Share by Application (2018-2023)

    • Table Gemphire Therapeutics Inc Company Profile

    • Table Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Revenue, Price and Gross (2018-2023)

    • Table The Medicines Company Company Profile

    • Table The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Revenue, Price and Gross (2018-2023)

    • Table Regeneron Pharmaceuticals Inc Company Profile

    • Table Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Revenue, Price and Gross (2018-2023)

    • Table Daewoong Co Ltd Company Profile

    • Table Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Revenue, Price and Gross (2018-2023)

    • Table LipimetiX Development Inc Company Profile

    • Table LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Revenue, Price and Gross (2018-2023)

    • Table CymaBay Therapeutics Inc Company Profile

    • Table CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US